Clinical Trial Update: Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine, paclitaxel, and cisplatin for advanced urothelial cancer (bladder cancer and transitional cell cancer of renal pelvis/uret…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Renal Pelvis and Ureter

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Status: COMPLETED